Tiotropium Bromide 9 mcg 120 metered doses/unit, Inhaler
Indian Army
KOLKATA, WEST BENGAL
Bid Publish Date
21-Jun-2025, 11:39 am
Bid End Date
12-Jul-2025, 12:00 pm
Location
Progress
RAQuantity
26445
Category
Budesunide Formeterol Inhalation powder Turbohaler 160 9ug dose
Bid Type
Two Packet Bid
Indian Army invites bids for Budesunide Formeterol Inhalation powder Turbohaler 160 9ug dose, Human Chorionic Gonadotrophin 5000 IU Amp HCG INJ, Breathe actuated inhaler tiotropium 9 mcg cfc free MDI 120 meter doses with dose counter, Levetiracetam 1000 mg Tab, Sevelamer carbonate 800 mg Tab in DEHRADUN, UTTARAKHAND. Quantity: 26445. Submission Deadline: 12-07-2025 12: 00: 00. Submit your proposal before the deadline.
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
KOLKATA, WEST BENGAL
Hqids
SOUTH ANDAMAN, ANDAMAN & NICOBAR
Indian Army
LUCKNOW, UTTAR PRADESH
Employees State Insurance Corporation (esic)
HYDERABAD, TELANGANA
Indian Army
DEHRADUN, UTTARAKHAND
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Budesunide Formeterol Inhalation powder Turbohaler 160 9ug dose | Budesunide and Formeterol Inhalation powder Turbohaler 160 9ug dose | 300 | no | bidhan@1234 | 30 |
| 2 | Human Chorionic Gonadotrophin 5000 IU Amp HCG INJ | Human Chorionic Gonadotrophin 5000 IU Amp HCG INJ | 525 | amp | bidhan@1234 | 30 |
| 3 | Breathe actuated inhaler tiotropium 9 mcg cfc free MDI 120 meter doses with dose counter | Breathe actuated inhaler tiotropium 9 mcg cfc free MDI 120 meter doses with dose counter | 300 | no | bidhan@1234 | 30 |
| 4 | Levetiracetam 1000 mg Tab | Levetiracetam 1000 mg Tab | 16,080 | no | bidhan@1234 | 30 |
| 5 | Sevelamer carbonate 800 mg Tab | Sevelamer carbonate 800 mg Tab | 9,240 | no | bidhan@1234 | 30 |
Discover companies most likely to bid on this tender
Experience Criteria
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
19-Aug-2025, 10:00 am
End
20-Aug-2025, 10:00 am
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Key insights about UTTARAKHAND tender market
The eligibility requirements include being a registered entity with a valid license to supply pharmaceutical products. Bidders should have prior experience in supplying similar products to government or military sectors and must comply with all regulatory standards to ensure product quality and safety.
The tender requires that Budesunide Formeterol Inhalation Powder must contain 160/9ug dose, manufactured according to recognized pharmaceutical standards. Additionally, the Human Chorionic Gonadotrophin must consist of 5000 IU in each ampule, meeting quality assurance protocols that validate efficacy and safety for clinical use.
Bidders must submit an Earnest Money Deposit (EMD) to demonstrate their commitment to the bidding process. The EMD amount and acceptable forms of payment will be specified in the tender documentation, and it is typically refunded upon successful contract execution or after a formal award announcement.
Proposals must be submitted electronically via the designated procurement platform where all documents should be uploaded in PDF or other specified formats. Bidders are encouraged to ensure that all documentation is clear and accessible to facilitate the evaluation process smoothly.
This tender offers tailored provisions for Micro, Small, and Medium Enterprises (MSEs), including simplified documentation and evaluation criteria. MSEs may receive priority in terms of order allocation and are encouraged to apply under the special benefits that enhance their participation in government tender processes.
Sign up now to access all documents
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS